Galderma Group AG (SWX:GALD)
Switzerland · Delayed Price · Currency is CHF 162.25
+1.35 (0.84%)
Sep 24, 2026, 5:30 PM CET
Galderma Group AG Stock Forecast
Stock Price Forecast
According to 17 analysts polled by S&P Global, Galderma Group AG stock has a consensus rating of "Buy" and an average price target of CHF 196.66. The average 1-year stock price forecast is 21.21% higher than the current stock price, while the lowest is CHF 131.25 (-19.11%) and the highest is CHF 265.40 (+63.57%).
Price Target: CHF 196.66 (+21.21%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Galderma Group AG stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 11 | 11 | 11 | 11 | 11 |
| Buy | 3 | 3 | 3 | 4 | 3 | 3 |
| Hold | 3 | 3 | 3 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 18 | 18 | 18 | 18 | 17 | 17 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Buy Reiterates CHF 200.00 | Buy | Reiterates | CHF 200.00 | +23.27% | Sep 10, 2026 |
| Barclays | Barclays | Buy Maintains CHF 210.00 → CHF 220.00 | Buy | Maintains | CHF 210.00 → CHF 220.00 | +35.59% | Sep 8, 2026 |
| RBC Capital No rating | RBC Capital | Hold Maintains CHF 175.00 | Hold | Maintains | CHF 175.00 | +7.86% | Jul 29, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains CHF 200.00 → CHF 203.00 | Buy | Maintains | CHF 200.00 → CHF 203.00 | +25.12% | Jul 24, 2026 |
| Jefferies | Jefferies | Buy Maintains CHF 205.00 | Buy | Maintains | CHF 205.00 | +26.35% | Jul 23, 2026 |
Financial Forecast
Revenue This Year
6.40B
from 5.24B
Increased by 22.15%
Revenue Next Year
7.46B
from 6.40B
Increased by 16.47%
EPS This Year
4.77
from 3.69
Increased by 29.27%
EPS Next Year
6.48
from 4.77
Increased by 35.93%
EPS and Forward PE are based on non-GAAP adjusted numbers.